Alpha Centric Advisors LLC Kal Vista Pharmaceuticals, Inc. Transaction History

Alpha Centric Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	SELL	$10.35 - $12.49 $1.32 Million - $1.59 Million	-127,500 Reduced 98.08%	2,500 $29,000
Q1 2024 Apr 24, 2024	SELL	$11.07 - $16.04 $77,490 - $112,280	-7,000 Reduced 5.11%	130,000 $1.54 Million
Q4 2023 Feb 14, 2024	BUY	$7.58 - $12.25 $15,160 - $24,500	2,000 Added 1.48%	137,000 $1.68 Million
Q2 2023 Aug 08, 2023	BUY	$7.73 - $10.57 $1.04 Million - $1.43 Million	135,000 New	135,000 $1.22 Million

125

47.8M

551K

110K

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $229M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

Get notified when there are updates to the investment portfolio of Alpha Centric Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Centric Advisors LLC with notifications on news.